Can-Fite Completes Long-Term Toxicology Studies with CF101 in Full GLP Compliance with US FDA

News   Jun 05, 2007

 
Can-Fite Completes Long-Term Toxicology Studies with CF101 in Full GLP Compliance with US FDA
 
 
 

RELATED ARTICLES

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal Trials

News

A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.

READ MORE

Lab Innovations 2018 – Registration Opens and Keynotes Announced

News

Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy